Baird Initiates Coverage On Immunocore Hldgs with Outperform Rating, Announces Price Target of $84
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Jack Allen has initiated coverage on Immunocore Holdings (NASDAQ:IMCR) with an Outperform rating and a price target of $84.
October 31, 2023 | 8:45 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Immunocore Holdings (NASDAQ:IMCR) has been initiated with an Outperform rating by Baird, with a price target of $84.
The Outperform rating from Baird indicates a positive outlook for Immunocore Holdings. The price target of $84 suggests a significant upside potential from the current price. This could lead to increased investor interest and a potential increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100